1m73

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1m73" size="450" color="white" frame="true" align="right" spinBox="true" caption="1m73, resolution 2.3&Aring;" /> '''CRYSTAL STRUCTURE OF...)
Line 1: Line 1:
-
[[Image:1m73.gif|left|200px]]<br />
+
[[Image:1m73.gif|left|200px]]<br /><applet load="1m73" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1m73" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1m73, resolution 2.3&Aring;" />
caption="1m73, resolution 2.3&Aring;" />
'''CRYSTAL STRUCTURE OF HUMAN PNP AT 2.3A RESOLUTION'''<br />
'''CRYSTAL STRUCTURE OF HUMAN PNP AT 2.3A RESOLUTION'''<br />
==Overview==
==Overview==
-
Purine nucleoside phosphorylase (PNP) catalyzes the phosphorolysis of the, N-ribosidic bonds of purine nucleosides and deoxynucleosides. In human, PNP is the only route for degradation of deoxyguanosine and genetic, deficiency of this enzyme leads to profound T-cell mediated, immunosuppression. PNP is therefore a target for inhibitor development, aiming at T-cell immune response modulation and its low resolution, structure has been used for drug design. Here we report the structure of, human PNP solved to 2.3A resolution using synchrotron radiation and, cryocrystallographic techniques. This structure allowed a more precise, analysis of the active site, generating a more reliable model for, substrate binding. The higher resolution data allowed the identification, of water molecules in the active site, which suggests binding partners for, potential ligands. Furthermore, the present structure may be used in the, new structure-based design of PNP inhibitors.
+
Purine nucleoside phosphorylase (PNP) catalyzes the phosphorolysis of the N-ribosidic bonds of purine nucleosides and deoxynucleosides. In human, PNP is the only route for degradation of deoxyguanosine and genetic deficiency of this enzyme leads to profound T-cell mediated immunosuppression. PNP is therefore a target for inhibitor development aiming at T-cell immune response modulation and its low resolution structure has been used for drug design. Here we report the structure of human PNP solved to 2.3A resolution using synchrotron radiation and cryocrystallographic techniques. This structure allowed a more precise analysis of the active site, generating a more reliable model for substrate binding. The higher resolution data allowed the identification of water molecules in the active site, which suggests binding partners for potential ligands. Furthermore, the present structure may be used in the new structure-based design of PNP inhibitors.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1M73 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with SO4 as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Purine-nucleoside_phosphorylase Purine-nucleoside phosphorylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.1 2.4.2.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1M73 OCA].
+
1M73 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=SO4:'>SO4</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Purine-nucleoside_phosphorylase Purine-nucleoside phosphorylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.1 2.4.2.1] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1M73 OCA].
==Reference==
==Reference==
Line 18: Line 17:
[[Category: Purine-nucleoside phosphorylase]]
[[Category: Purine-nucleoside phosphorylase]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Basso, L.A.]]
+
[[Category: Basso, L A.]]
[[Category: Canduri, F.]]
[[Category: Canduri, F.]]
-
[[Category: Jr., W.F.De.Azevedo.]]
+
[[Category: Jr., W F.De Azevedo.]]
-
[[Category: Olivieri, J.R.]]
+
[[Category: Olivieri, J R.]]
-
[[Category: Palma, M.S.]]
+
[[Category: Palma, M S.]]
-
[[Category: Santos, D.Marangoni.Dos.]]
+
[[Category: Santos, D Marangoni Dos.]]
-
[[Category: Santos, D.S.]]
+
[[Category: Santos, D S.]]
-
[[Category: Santos, G.C.]]
+
[[Category: Santos, G C.]]
-
[[Category: Silva, R.G.]]
+
[[Category: Silva, R G.]]
[[Category: SO4]]
[[Category: SO4]]
[[Category: crystallography]]
[[Category: crystallography]]
Line 33: Line 32:
[[Category: synchrotron]]
[[Category: synchrotron]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 18:08:19 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:52:12 2008''

Revision as of 11:52, 21 February 2008


1m73, resolution 2.3Å

Drag the structure with the mouse to rotate

CRYSTAL STRUCTURE OF HUMAN PNP AT 2.3A RESOLUTION

Contents

Overview

Purine nucleoside phosphorylase (PNP) catalyzes the phosphorolysis of the N-ribosidic bonds of purine nucleosides and deoxynucleosides. In human, PNP is the only route for degradation of deoxyguanosine and genetic deficiency of this enzyme leads to profound T-cell mediated immunosuppression. PNP is therefore a target for inhibitor development aiming at T-cell immune response modulation and its low resolution structure has been used for drug design. Here we report the structure of human PNP solved to 2.3A resolution using synchrotron radiation and cryocrystallographic techniques. This structure allowed a more precise analysis of the active site, generating a more reliable model for substrate binding. The higher resolution data allowed the identification of water molecules in the active site, which suggests binding partners for potential ligands. Furthermore, the present structure may be used in the new structure-based design of PNP inhibitors.

Disease

Known diseases associated with this structure: Neutral lipid storage disease with myopathy OMIM:[609059], Nucleoside phosphorylase deficiency, immunodeficiency due to OMIM:[164050]

About this Structure

1M73 is a Single protein structure of sequence from Homo sapiens with as ligand. Active as Purine-nucleoside phosphorylase, with EC number 2.4.2.1 Full crystallographic information is available from OCA.

Reference

Crystal structure of human purine nucleoside phosphorylase at 2.3A resolution., de Azevedo WF Jr, Canduri F, dos Santos DM, Silva RG, de Oliveira JS, de Carvalho LP, Basso LA, Mendes MA, Palma MS, Santos DS, Biochem Biophys Res Commun. 2003 Aug 29;308(3):545-52. PMID:12914785

Page seeded by OCA on Thu Feb 21 13:52:12 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools